Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. FDA puts Avita Medical’s ReCell burn treatment on the fast track
Avita Medical said that the FDA put its ReCell autologous cell harvesting device on the fast track, granting expedited access pathway status to the burn treatment.
The decision accelerates the timeline for ReCell’s approval, which Avita had expected to occur in the 3rd quarter of 2017, the company said. Read more
2. Medtronic, Germany’s Phenox to open new plants in Ireland
Medtronic and German medical device maker Phenox are each planning to open new manufacturing plants in Galway, Ireland.
Fridley, Minn.-based Medtronic said it plans to spend about $14.3 million (€13 million) building a new, 20,000-square-foot facility will be used to make its In.Pact Admiral drug-coated balloon. The plant is expected to employ about 100 workers, the company said. Read more
1. BD CEO Forlenza: We’re not selling surgical instruments biz
Rumors that Becton Dickinson is mulling the sale of its V. Mueller surgical instruments after closing the $12.2 billion acquisition of CareFusion are not true, chairman & CEO Vincent Forlenza said.
“We are not selling our surgical business. On the other hand, we are doing a market check on our respiratory business, but we have not made a decision on whether to sell it or not. We are evaluating on what to do with the respiratory business,” Forlenza told India’s LiveMint blog. Read more
The post MassDevice.com +3 | The top 3 medtech stories for December 14, 2015 appeared first on MassDevice.
from MassDevice http://ift.tt/1SXCLjY
Cap comentari:
Publica un comentari a l'entrada